Cell-type-specific G protein-coupled receptor (GPCR) signaling regulates distinct neuronal responses to various stimuli and is essential for axon guidance and targeting during development. However, its function in axonal regeneration in the mature CNS remains elusive. We found that subtypes of intrinsically photosensitive retinal ganglion cells (ipRGCs) in mice maintained high mammalian target of rapamycin (mTOR) levels after axotomy and that the light-sensitive GPCR melanopsin mediated this sustained expression. Melanopsin overexpression in the RGCs stimulated axonal regeneration after optic nerve crush by up-regulating mTOR complex 1 (mTORC1). The extent of the regeneration was comparable to that observed after phosphatase and tensin homolog (Pten) knockdown. Both the axon regeneration and mTOR activity that were enhanced by melanopsin required light stimulation and Gq/11 signaling. Specifically, activating Gq in RGCs elevated mTOR activation and promoted axonal regeneration. Melanopsin overexpression in RGCs enhanced the amplitude and duration of their light response, and silencing them with Kir2.1 significantly suppressed the increased mTOR signaling and axon regeneration that were induced by melanopsin. Thus, our results provide a strategy to promote axon regeneration after CNS injury by modulating neuronal activity through GPCR signaling.
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axon regeneration | neuronal activity | melanopsin | GPCR | mTOR S evered axons in the adult mammalian CNS do not spontaneously regenerate to restore lost functions. The failure of axons to regenerate is mainly attributed to the diminished growth capacity of neurons as well as an inhibitory environment (1) (2) (3) (4) (5) (6) . Optic nerves have been extensively studied for mechanisms regulating axon regeneration in CNS. When presented with permissive substrates such as a sciatic nerve graft, only axons of small populations of retinal ganglion cells (RGCs) regrow into the graft (7) . When the intrinsic growth program is boosted, distinct subtypes of RGCs regenerate their axons (8) . These findings indicate that the differential responses of RGCs to axotomy and growth stimulation are related to their intrinsic properties. One of the critical determinants of the intrinsic regenerative abilities of adult RGCs is neuronal mammalian target of rapamycin (mTOR) activity (9) . In retinal axons, the loss of the potential to regrow is accompanied by down-regulation of mTOR activity in RGCs with maturation, and further reduction after axotomy. However, a small percentage of RGCs maintain high mTOR activation levels after optic nerve crush (9, 10) . One can ask whether specific subsets of RGCs differ in their ability to maintain mTOR activation. Deciphering the physiological mechanism behind the mTOR maintenance could help elucidate the differential responses of neurons to injury signals and develop strategies to promote axon regeneration.
Type 1 melanopsin expressing intrinsically photosensitive retinal ganglion cells (M1 ipRGCs) and αRGCs are resistant to axotomy-induced cell death (8, 11) . M1 ipRGCs mainly mediate the circadian photoentrainment and the pupillary light reflex function, with their dendrites stratifying in the outermost sublamina of the inner plexiform layer. αRGCs have largest somata among RGCs, and their dendrites are rich in a neurofilament-associated epitope SMI32. Interestingly, axotomy causes dendritic arbor retraction in αRGCs, but not in M1 ipRGCs (10, 11) , suggesting subtype-specific responses to lesions. We hypothesized that mTOR signaling could be differentially regulated in these types of RGCs. Here, we show that M1-M3 ipRGCs but not αRGCs maintain mTOR on injury and that this effect is diminished in melanopsin knockout (KO) mice. Ectopic melanopsin overexpression in RGCs promoted axonal regeneration by activating mTORC1. Furthermore, we provide evidence that mTOR up-regulation and axon regeneration depend on light stimulation and Gq/11 signaling and, subsequently, enhanced neuronal activity. Together, our work identifies a mechanistic link between axon regeneration and neuronal activity in vivo and provides an intrinsic factor that can be exploited to promote neural repair after injury.
Results
Melanopsin Regulates mTOR Activity in RGCs. We started the investigation using mice in which GFP expression is driven by the melanopsin promoter (Opn4-GFP) to mark ipRGCs (12), whereas SMI32 staining was used to mark αRGCs and Tuj1 staining was used as a general RGC marker. In the Opn4-GFP mouse line, GFP
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Damage to axons in the CNS typically results in permanent functional deficits. Boosting intrinsic programs such as mammalian target of rapamycin (mTOR) signaling can dramatically augment the axon regenerative capacity of injured neurons. Because certain types of neurons respond to axotomy by maintaining their mTOR activation, we hypothesized that it might be helpful to use this property to promote axon regeneration. We found that the light-responsive G protein-coupled receptor (GPCR) melanopsin could promote axonal regeneration after optic nerve crush by activating mTOR. We also showed that light, Gq/11 signaling, and neuronal activity contribute to the mechanism that underlies this effect. Activating Gq signaling through a chemogenetic approach promoted axon regeneration. Thus, we provided evidence for modulating neuronal activity through GPCR signaling in regulating intrinsic axon growth capacity.
mainly labels M1-M3 ipRGCs (Fig. S1A) , which express higher levels of melanopsin than other types of ipRGCs. More than 95% of the GFP + cells could be labeled with a melanopsin antibody (Fig. S1B) . We examined the levels of phosphorylated S6 ribosomal protein (pS6) signal, an indicator of mTOR, in adult RGCs with or without axotomy. In intact mice, ∼95% of the GFP + ipRGCs expressed high levels of pS6 (Fig. 1A) . One day after injury, the percentage of pS6 + RGCs was decreased to half (Fig. 1B) . However, the GFP + ipRGCs maintained a similar level of pS6 signal (Fig. 1C) . Even at 2 wk after injury, when the M1 ipRGCs were the predominant surviving ipRGCs (8), pS6 was still highly expressed in more than 70% of the GFP + cells (Fig. S1 C and D) . With respect to the αRGCs, pS6 was highly expressed in ∼60% of the intact SMI32 + cells with large somata. After axotomy, pS6 expression in the αRGCs was significantly suppressed (Fig. S1 E and F) . Our results indicate that M1-M3 ipRGCs maintained mTOR activation after axotomy.
M1-M3 ipRGCs express high levels of melanopsin. We next asked whether melanopsin played a role in mTOR expression in M1-M3 ipRGCs after axotomy. We crossed knock-in mice (Opn4-Cre) that express Cre recombinase in place of melanopsin within the ORF (13) to a Cre-dependent tdTomato reporter line (Rosa26-TMT). M1-M3 and other ipRGCs are genetically labeled in Opn4Cre/ + ;TMT mice, whereas in Opn4Cre/Cre;TMT mice, melanopsin is deleted from ipRGCs. TMT + ipRGCs represented all types of ipRGCs, and GFP + ipRGCs represented M1-M3 ipRGCs. The pS6 signal was in more than 30% of TMT + ipRGCs in uninjured animals ( Fig. 1 D and E) . The pS6 level did not significantly differ between the Opn4 heterozygous and Opn4 KO mice ( Fig. 1 D and E) . One day after injury, in contrast to GFP + ipRGCs, the pS6 + cells in TMT + ipRGCs decreased more than half in the Opn4 heterozygous mice (Fig. 1 D and E) . It has been reported that On αRGCs are M4 ipRGCs, in which a lower level of melanopsin is expressed. Because axotomy suppressed pS6 in αRGCs (Fig. S1 E and F), it is likely M4 ipRGCs contributed to ipRGCs that downregulated pS6. Consistent with the pS6 maintenance in GFP + ipRGCs, some TMT + ipRGCs still expressed a high level of pS6 after injury. In Opn4 KO mice, pS6 was dramatically suppressed in the vast majority of TMT + ipRGCs, presumably including M1-M3 types, leaving few TMT + cells that expressed pS6 ( Fig. 1 D and E) . Thus, our results suggest that melanopsin is required for the maintenance of mTOR in M1-M3 cells after axotomy.
Then we assessed whether melanopsin regulates mTOR activation in RGCs by a gain-of-function experiment. We injected adeno-associated virus (AAV)-expressing melanopsin (AAV-Mela) into the eyes of mice to infect RGCs in retinas (14) . Within the whole retina, ∼30% of RGCs were strongly melanopsin-positive, and within the optimally infected areas, more than 60% were positive 4 wk after infection ( Fig. S2 A and B) . These numbers likely underestimated the AAV infection rate resulting from the sensitivity of immunostaining. After injecting AAV-expressing Cre recombinase (AAV-Cre) at a similar titer into a Rosa26-TMT reporter mouse, the AAV infected more than 90% of all RGCs (Fig.  S2C ). In mice with AAV-Mela injection, levels of pS6 were high in more than 40% of the RGCs (Fig. 1 F and G) , higher than control mice with AAV-GFP injection. One day after nerve crush in the AAV-GFP-injected mice, pS6 levels in Tuj1-positive RGCs were reduced. In the AAV-Mela-injected mice, pS6 levels were maintained (Fig. 1 F and G) . Thus, melanopsin stimulates mTOR activity in RGCs.
Melanopsin Overexpression Promotes Optic Nerve Regeneration
Through an mTORC1-Dependent Mechanism. To determine whether melanopsin could promote axonal regeneration after nerve injuries, we crushed the optic nerves of mice infected with AAVMela. Two weeks later, we traced axons by injecting cholera toxin B conjugated with Alexa 488 (CTB) into the injured eyes. Axonal regeneration was evident in the AAV-Mela-injected mice, but not in the control mice ( Fig. 2 A and B) . In some cases, axons extended more than 2 mm (Fig. S3A ). Tuj1 staining showed that the rates of RGC survival were similar between the two groups (Fig. 2C ). The lack of survival effect may be partially explained by which phosphorylated AKT in RGCs was not enhanced by melanopsin overexpression (Fig. S3B) . Levels of pS6 in Tuj1-postive RGCs were also increased at 2 wk after nerve crush ( Fig. S3 C and D) . Interestingly, RGCs that overexpressed melanopsin did not show hypertrophic cell bodies or a bulging morphology compared with neurons in which Pten was deleted (Fig. S3 E-G). This likely suggested that mTOR signaling boosted by melanopsin was not hyperactive but was still sufficient for growth. Thus, melanopsin overexpression promotes retinal axon regeneration after optic nerve crush.
We further assessed whether mTOR activation is functionally required for the regenerative effects induced by melanopsin. Rapamycin, a potent and specific inhibitor of mTOR, suppressed the axonal regeneration promoted by melanopsin ( Fig. 2 D and E), as well as the induced increase in pS6 levels (Fig. S4A ). To investigate whether mTOR signaling definitively mediates axon regeneration, we took a genetic approach and inactivated the mTOR kinase, using mTOR floxed mice (15) . AAV-Cre and AAVMela were coinjected into mTOR floxed mice. Consistent with the effect of rapamycin, mTOR KO dramatically inhibited the axonal regeneration induced by melanopsin ( Fig. 2 D and E) . mTOR acts through two signaling complexes; namely, mTORC1 and mTORC2.
To determine whether mTORC1 mediated the regeneration, we used Raptor floxed mice. Raptor is a required component of mTORC1 signaling, and these KO mice have been used to specifically inactivate mTORC1 signaling (16) . Raptor deletion in RGCs blocked regeneration to a degree similar to that observed in the mTOR KO mice (Fig. 2 D and E) , indicating mTORC1 played a major role in the effect. The deletion of mTOR or Raptor in neurons that were infected by AAV-Cre was verified by the loss of pS6 signal (Fig. S4B) . Either KO had a modest effect on RGC survival (Fig. S4C ), but it was insufficient to account for the effect on axonal regeneration. We also examined additional signaling pathways that have been shown to increase the intrinsic growth potential of injured adult RGCs: STAT3 (17) and MEK (18) . Neither the p-STAT3 nor the p-ERK staining showed a detectable difference between the two groups (Fig. S4D) . Therefore, both pharmacological and genetic evidence place mTORC1 downstream of melanopsin in a molecular pathway that promotes regeneration.
Melanopsin Promotes Comparable Axon Regeneration to Pten Inhibition.
Melanopsin overexpression activated mTOR without causing hypertrophy in RGCs (Fig. S3D) , which is potentially an undesired feature developed in neurons with Pten deletion. It motivated us to compare the melanopsin effect with Pten inhibition on axon regeneration. We injected AAV-Mela, AAV-shRNA that targeted Pten (shPten), AAV-shRNA that targeted suppressor of cytokine signaling 3 (Socs3) (shSocs3), or a combination of these factors into the vitreous bodies of mice and waited 3 wk. We then examined axonal regeneration 2 wk after optic nerve crush. AAV-Mela induced axonal regeneration that was comparable to that induced by shPten or shSocs3 ( Fig. S5 A and B) . When AAV-Mela was combined with shSocs3, but not with shPten, we observed synergistic growth that was comparable to the effect of the double knockdown of Pten and Socs3 ( Fig. S5 A and B) , which is consistent with a previous finding that mTOR and STAT3 coactivation in RGCs promotes sustained axon regeneration (17) . In addition, AAVMela did not further increase the synergistic growth induced by shPten and shSocs3 ( Fig. S5 A and B) . Thus, melanopsin overexpression may provide an alternative strategy to Pten inhibition for axon regeneration.
Melanopsin Promotes Axon Regeneration of αRGCs. Then we investigated the cell types that regenerated their axons. The stimulation of optic nerve regeneration via Pten inhibition is confined to αRGCs (8). With melanopsin overexpression, injured αRGCs exhibited elevated pS6 levels ( Fig. S6 A and B) , but cocaine-and amphetamine-regulated transcript-positive RGCs did not (Fig.  S6C) . We injected Fluorogold (FG) into the optic nerve distal to the lesion site to label RGCs with axon regeneration, as previously described (9) . In animals with AAV-Mela, 95% of the labeled RGCs were positively stained with SMI32 ( Fig. S6 D-F) . In addition, a similar result (92%) was achieved by doing ex vivo labeling in isolated retinas (Fig. S6G) . Thus, the majority of regenerating fibers were from SMI32 + αRGCs. However, it raised a question of why M1 ipRGCs, which express a high level of melanopsin, do not regenerate after injury. By using Pten f/f ;Socs3 f/f ;Opn4-GFP mice, we showed that deletion of both Pten and Socs3 robustly promoted CTB-labeled axons beyond the lesion site but did not drive GFP + axons to regenerate (Fig. S6H) . The mechanism remains unclear. Then, we assessed whether the effect of melanopsin was cell autonomous. AAV-shRNA against Bax (AAV-shBax) significantly enhances the survival of RGCs (Fig. S7 A and B) , but not the regeneration induced by melanopsin (Fig. S7C) . We also quantified the percentage of retrograde-labeled RGCs expressing melanopsin after optic nerve crush. More than 95% of labeled RGCs expressed both melanopsin and SMI32. Because M4 ipRGC (On αRGCs) cannot be detected by typical immunostaining of melanopsin, it suggested that the melanopsin expression came from AAV-Mela. The results support that the effect of melanopsin overexpression is most likely cell autonomous.
Melanopsin Stimulates Regeneration in a Light-Dependent Manner.
Next, we investigated the mechanism or mechanisms that melanopsin activates mTOR.
Because melanopsin is a light-sensitive G protein-coupled receptor (GPCR) molecule (19) , we tested the idea that light stimulation may be required for melanopsin to maintain mTOR. Before assessing the effect of light on RGCs that overexpressed melanopsin, we began our investigation in normal RGCs. We dark-adapted Opn4-GFP mice for 1 d and then stained retinas for pS6. In darkadapted retinas, ∼6% of total RGCs expressed high levels of pS6 versus ∼10% in mice under normal light conditions, and few if any GFP + ipRGCs maintained high levels of pS6 ( Fig. S8 A and B) . In contrast, pS6 levels in the αRGCs were not affected by dark adaption ( Fig. S8 C and D) . Dark adaptation and axotomy suppressed pS6 in M1-M3 RGCs and αRGCs, respectively, suggesting two different mechanisms regulating neuronal mTOR. These findings were also consistent with the notion that pS6 was dramatically downregulated in injured ipRGCs in Opn4 KO mice, indicating that melanopsin may function as a photo transducer to mediate mTOR signaling in M1-M3 ipRGCs. Thus, melanopsin maintains high pS6 levels in M1-M3 ipRGCs in a light-dependent manner.
To determine whether light could also affect the mTOR activation and axon regeneration induced by melanopsin overexpression, we infected RGCs with AAV-Mela, crushed the optic nerves, and put the mice in the dark. Deprivation of light blocked regeneration, as shown by CTB tracing 2 wk later ( Fig. 3 A and B) . The pS6 levels, which were normally elevated by melanopsin, were also largely suppressed by darkness (Fig. 3 C and D) . RGC survival was not affected (Fig. S8E) . Continuous light stimulation enhanced and maintained mTOR activity in injured SMI32
+ RGCs in mice with AAV-Mela, but not in control mice (Fig. S8F) . In contrast, deprivation of light did not suppress axon regeneration induced by Pten inhibition (Fig. S8G) . These data suggest light may function upstream of melanopsin-mediated signaling to promote regeneration.
Melanopsin Promotes mTOR-Dependent Regeneration by Activating
Gq/11 Signaling. Melanopsin has been experimentally shown to require G protein signaling for its light responsiveness (20) . We therefore examined whether melanopsin regulates mTOR through the canonical GPCR signaling pathway. The endogenous G proteins that are downstream of melanopsin in ipRGCs are unclear, but in heterologous expression systems, melanopsin may signal primarily by coupling with G protein or proteins of the Gq family upon light stimulation (20) . Then we tested whether Gq/11 signaling enhances mTOR activation. In Neuro2A cells, compared with GFP or Gq WT transfection, transfection with constitutively active Gq mutants (GqQL) increased phosphorylated P70 S6 kinase (pS6K) levels; this effect was blocked by rapamycin or torin (Fig. S9A) , suggesting mTORC1 activation. The pS6 level was also increased (Fig. S9B) . To mimic the physiological conditions of Gq/11 signaling in RGCs, we took a chemogenetic approach. A mutant M3 muscarinic GPCR hM3Dq, which is also called a designer receptor exclusively activated by a designer drug (DREADD-Gq), can be used to selectively activate Gq/11 signaling when expressed in vivo. This Gq/11-coupled designer GPCR cannot be activated by its natural ligand (acetylcholine), but becomes activated by clozapine N-oxide (CNO), an otherwise pharmacologically inert compound (21) . We injected AAVs expressing DREADD-Gq (AAV-DREADD-Gq) into the eyes of WT mice. Four weeks later, mice were dark-adapted for 24 h before we examined the effect of CNO. In AAV-DREADD-Gq-injected mice without an injury, pS6 signaling was increased in RGCs 2 h after the administration of CNO and sustained at least to 12 h (Fig.  3E and Fig. S9 C and D) . After optic nerve injury, the pS6 level was elevated at 2 h but decreased at 6 h, and returned the basal level at 12 h (Fig. S9E) . Then we tested whether Gq/11 signaling was required for the melanopsin-mediated axon regeneration. The heterotrimeric G proteins Gq and G11 are often functionally redundant. We injected two AAVs, each of which encoded an shRNA directed against Gnaq (shGq) or Gna11 (shG11), together with AAV-Mela. We validated the efficacy of the shRNAs by Western blot analysis (Fig. S9F ). Gq and G11 knockdown significantly suppressed the axon regeneration normally induced by melanopsin overexpression (Fig. 3 F and G) . To assess whether activating Gq/11 signaling enhances axonal regeneration, we injected AAV-DREADD-Gq, performed optic nerve crush, and intraperitoneally administered CNO (5 mg/kg) into mice twice daily for 2 wk. In AAV-DREADDGq-injected mice, CNO treatment resulted in a significant increase in axonal growth compared with control groups. Neither CNO nor AAV-DREADD-Gq with vehicle has any growth-promoting effect (Fig. 3 H and I) . Thus, Gq/11 may function as a downstream effector of melanopsin upon light stimulation to mediate axon regeneration.
Neuronal Activity in RGCs Modulated by Melanopsin Overexpression
Is Essential for Regeneration. We next asked how Gq/11 signaling enhances mTOR signaling. Orexin/GPCR signaling activates mTOR via calcium influx (22) . Upon light stimulation, expression of melanopsin in RGCs can result in neuronal depolarization, the triggering of action potentials, and calcium influx into neurons. We investigated whether calcium plays a role in Gq/11-stimulated mTORC1 activation. In Neuro2A cells, the application of BAPTA/AM (BAPTA), a cell-permeable calcium chelator, to the growth media diminished the S6K phosphorylation that is normally induced by constitutive Gq activation (Fig. S10A) . To determine whether extracellular calcium is essential for Gq/11 signaling to mTORC1, we treated Neuro2A cells with media that contained or lacked Ca
2+
. The results showed that extracellular Ca 2+ enhanced Gq/11 but not insulin-like growth factor (IGF)-induced S6K phosphorylation (Fig. S10 A-C) . To determine whether calcium influx was sufficient to activate mTORC1, we incubated Neuro2A cells with ionomycin that triggers extracellular calcium influx. Ionomycin induced the phosphorylation of S6K and S6 (Fig. S10D) , and the effect was abolished by treatment with rapamycin or torin (Fig. S10E) . This calcium-stimulated S6K phosphorylation was also abolished by treatment with BAPTA (Fig. S10F) . Taken together, these results indicate that Gq/11 signaling enhances mTOR via calcium influx.
Although we showed that light-induced Gq/11 signaling is required for melanopsin to activate mTORC1, and the effect is related to calcium signaling, it remained unclear how mTORC1 signaling could be sustained for weeks for axon regeneration in vivo. Neuronal activity has been shown to regulate S6 phosphorylation in animals, and different activity-related stimuli may induce pS6 expression with varying efficiency and kinetics and for varying durations (23); furthermore, DREADD-Gq has been used to enhance neuronal firing in animals (21) . We then asked whether neuronal activity could mediate the regeneration effect. To test whether melanopsin overexpression modulated neuronal activity in RGCs, retinas were isolated and presented with periodic light flashes. Action potentials from RGCs were recorded extracellularly with a multielectrode array (MEA). Population data revealed that both the response amplitude, as measured by average firing rate, and the response duration (Fig. S11A) were significantly higher in retinas treated with AAV-Mela compared with control retinas (Fig. 4 A and B) . Spontaneous firing, both after dark adaptation and under moderate illumination, was also enhanced (Fig. S11 B and C) . This increase was returned to control levels by the coinjection of AAV-expressing Kir2.1 (Fig. 4  A and B) , an inward-rectifying potassium ion channel that causes hyperpolarization and a substantial decrease in neural activity (24) . In the optic nerve crush model, AAV-Kir2.1 significantly inhibited the axon regeneration that was normally stimulated by melanopsin (Fig. 4 C and D) . It also suppressed pS6 expression in RGCs (Fig. 4 E and F) , indicating that mTOR signaling in RGCs is activity-dependent. Taken together, these results suggest that melanopsin boosts axon regeneration by enhancing mTORC1 in a neuronal activity-dependent manner.
Discussion
We showed that injured M1-M3 ipRGCs maintain mTOR by expressing a high level of melanopsin. Melanopsin overexpression in RGCs promoted axonal regeneration after optic nerve crush by activating mTORC1 to an extent comparable to that induced by Pten inhibition. Light, Gq/11 signaling, and neuronal activity enhanced mTOR and axon regeneration. Furthermore, specifically activated Gq/11 signaling in RGCs through DREADD by systematic delivery of CNO enhances the regrowth. These findings therefore provide a rationale for modulating neuronal activity through GPCRs to stimulate axonal regeneration after CNS injuries.
Various GPCRs are expressed on the surface of neurons, and they mediate physiological responses to hormones, neurotransmitters, and environmental stimulants. GPCRs have multiple effects on neuronal development, including neuronal differentiation, axon guidance, and targeting (25) . In Caenorhabditis elegans, endogenous arachidonyl ethanolamide activates Go signaling and inhibits axonal regeneration by antagonizing the Gq-PKC-JNK pathway (26) . In our study, we showed that light activates melanopsin and the Gq/11 signaling to stimulate mTOR. It is most likely that mTOR depends on an elevation in cytoplasmic calcium. Melanopsin activates Gq/11 signaling that subsequently increases neuronal activity and calcium influx to a degree that may be necessary to sustain long-term mTOR activation in RGCs without causing cell death. Indeed, a group of RGCs showed a higher frequency of firing above 20 Hz after melanopsin overexpression. Although we lack direct evidence that the regenerated axons belong to the neurons that are more active, silencing these neurons suppresses mTOR activation and axonal regeneration. During development, neuronal activity is essential for axon growth and wiring (27) . In vitro, postnatal RGCs respond to growth factors by elongating axons after depolarization (28) . In adults, electrical stimulation has been shown to promote the regeneration of crushed optic nerves over short distances (29) . Optogenetic stimulation enhances axon regeneration in worms after laser axotomy by regulating localized calcium release (29) . Our findings may provide a mechanistic link between axon regeneration and elevated neuronal activity. mTOR activation may also serve as a readout for the optimum electrical or optogenetic stimulation to promote regrowth in vivo.
Our results also raise the question of why M1 ipRGCs do not regenerate after injury even though they survive axotomy and express a high level of melanopsin. Duan et al. (8) indirectly showed that axons of M1 ipRGCs are not regenerated after Pten inhibition, suggesting that enhancing mTOR is not sufficient to boost the growth of M1 ipRGCs. We showed that Opn4-GFP + axons also did not regenerate even after deleting both Pten and Socs3 genes. It may suggest that other mechanisms than mTOR or Stat3 regulate the axon regeneration in M1 ipRGCs, because they can regenerate when presented with a peripheral graft (30) . Interestingly, M1 ipRGCs have intraretinal axon collaterals that terminate in the inner plexiform layer of the retina (31) . In dorsal root ganglion neurons, a surviving intact branch suppresses axon regeneration after a laser-induced lesion (32) . The suppression effect from intact collaterals could partially account for the lack of regeneration in M1 ipRGCs in the inhibitory environment.
Pten inhibition activates mTOR and promotes corticospinal tract regeneration after spinal cord injury (33, 34) , indicating the translational potential of this strategy. However, Pten inhibition also activates additional pathways that likely contribute to its oncogenic activity. In the retina, melanopsin does not cause hypertrophy in RGCs, suggesting that neuronal mTOR is not hyperactive in these cells, as it is in neurons with Pten deletion, yet melanopsin-induced mTOR was sufficient for regrowth. Melanopsin may provide an alternative method that bypasses this potential risk with Pten inhibition. Overall, by identifying melanopsin as an mTOR booster through Gq/11 signaling and neuronal activity, our study provides a strategy to promote axon regeneration, and also an approach to search for mTOR activators in different types of neurons.
Materials and Methods
All experimental procedures were performed in compliance with animal protocols that were approved by the Animal and Plant Care Facility at the Hong Kong University of Science and Technology. Details on all experimental procedures used in this study, including animals, AAV construction, surgeries, tissue processing, immunostaining, quantification, cell culture, electrophysiology, and statistics can be found in the SI Materials and Methods.
